Weitz Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-383,236
Closed -$51.2M 82
2018
Q4
$51.2M Sell
383,236
-122,034
-24% -$20M 2.35% 14
2018
Q3
$96.2M Sell
505,270
-144,771
-22% -$26.6M 3.92% 9
2018
Q2
$108M Sell
650,041
-20,358
-3% -$3.27M 4.61% 6
2018
Q1
$113M Buy
670,399
+20,084
+3% +$3.37M 4.77% 6
2017
Q4
$106M Buy
650,315
+126,505
+24% +$22.7M 4.43% 6
2017
Q3
$107M Buy
523,810
+41,915
+9% +$9.75M 4.41% 5
2017
Q2
$117M Sell
481,895
-30,508
-6% -$7.17M 5.05% 5
2017
Q1
$122M Sell
512,403
-125,330
-20% -$29.2M 5.03% 4
2016
Q4
$134M Buy
637,733
+27,770
+5% +$5.75M 5.32% 4
2016
Q3
$140M Buy
609,963
+14,002
+2% +$3.42M 5.28% 4
2016
Q2
$138M Buy
595,961
+291,239
+96% +$67.1M 5.08% 4
2016
Q1
$81.7M Buy
304,722
+108,552
+55% +$31.1M 2.86% 10
2015
Q4
$61.3M Buy
196,170
+8,563
+5% +$2.55M 2.09% 15
2015
Q3
$51M Buy
+187,607
New +$57.6M 1.58% 25

Other funds holding AGN

Weitz Investment Management's AGN Position: Q1 2019 in Review

Weitz Investment Management sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 383,236 shares — an estimated $51.2M sold.

Weitz Investment Management first reported a position in AGN in Q3 2015 and held it in 14 quarters. The position peaked at $140M in Q3 2016. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Weitz Investment Management reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Weitz Investment Management sold 383,236 Allergan plc shares in Q1 2019, an estimated $51.2M.
  • Weitz Investment Management first reported a position in Allergan plc in Q3 2015 and held it in 14 quarters.
  • Weitz Investment Management's Allergan plc position peaked at $140M in Q3 2016.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Weitz Investment Management's 13F filing for Q1 2019, filed 14 May 2019.